Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
June 25, 2019
Patent Application Number
15691408
Date Filed
August 30, 2017
Patent Citations Received
Patent Primary Examiner
Patent abstract
The present disclosure provides MAT2A inhibitor compounds that are useful as therapeutic agents for treating malignancies, and wherein the compounds conform to general formula (IA):
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.